Almeida MI, Reis RM, Calin GA. MicroRNA history: discovery, recent applications, and next frontiers[J]. Mutat Res, 2011, 717(1⁃2): 1⁃8. DOI: 10.1016/j.mrfmmm.2011.03.009.
[2]
Ichihara A, Jinnin M, Oyama R, et al. Increased serum levels of miR⁃1266 in patients with psoriasis vulgaris[J]. Eur J Dermatol, 2012, 22(1): 68⁃71. DOI: 10.1684/ejd.2011.1600.
[3]
Taganov KD, Boldin MP, Chang KJ, et al. NF⁃kappaB⁃dependent induction of microRNA miR⁃146, an inhibitor targeted to signaling proteins of innate immune responses[J]. Proc Natl Acad Sci U S A, 2006, 103(33): 12481⁃12486. DOI: 10.1073/pnas.0605298103.
[4]
Fischer M, Harvima IT, Carvalho RF, et al. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranu⁃lation⁃independent chemokine secretion[J]. J Clin Invest, 2006, 116(10): 2748⁃2756. DOI: 10.1172/JCI24274.
[5]
Løvendorf MB, Mitsui H, Zibert JR, et al. Laser capture microdissection followed by next⁃generation sequencing identifies disease⁃related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis[J]. Exp Dermatol, 2015, 24(3):187⁃193. DOI: 10.1111/exd.12604.
[6]
Koga Y, Jinnin M, Ichihara A, et al. Analysis of pattern of serum microRNA levels in patients with psoriasis[J]. J Dermatol Sci, 2014, 74(2): 170⁃171. DOI: 10.1016/j.jdermsci. 2014.01.005.
[7]
Delic, Eisele C, Schmid R, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients[J/OL]. PLoS One, 2016, 11(3): e0150154. http://www.ncbi.nlm.nih.gov/pubmed/?term= Delic+2016+e0150154. DOI: 10.1371/journal.pone.0150154.
Yan⁃Chun L, Hong⁃Mei Y, Zhi⁃Hong C, et al. MicroRNA⁃192⁃5p promote the proliferation and metastasis of hepatocellular carcinoma cell by targeting SEMA3A[J/OL]. Appl Immunohistochem Mol Morphol, 2015. [published online ahead of print Nov 17, 2015]. DOI: 10.1097/PAI. 0000000000000296.